Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03406897 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
A Phase 1 study, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT03406897 is a Phase 1 study that has completed, run by Rodolfo Alejandro. The registered enrollment target is 27 participants.
The verdict
NCT03406897, a Phase 1 study, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.
Interventions
- DRUG Cholecalciferol
- DRUG Omega 3 fatty acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03406897
The ClinicalTrials.gov registry entry for NCT03406897 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rodolfo Alejandro, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT03406897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03406897 about?
NCT03406897 is a clinical study titled "Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients". The investigator propose to test the safety and efficacy of a regimen that combines Omega-3 Fatty Acids and Vitamin D in a design that considers timing and duration of administration in relation to their effects and predicted synergies.
What is the current status of trial NCT03406897?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2018-07-23. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03406897?
The interventions under investigation include: Cholecalciferol (DRUG), Omega 3 fatty acid (DRUG).
Who is sponsoring clinical trial NCT03406897?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.